| INTRODUC TI ON
Hepatocellular carcinoma (HCC) is one of the main causes of cancerrelated deaths worldwide. 1 Although great improvements have been achieved in the treatment strategy for HCC, the prognosis of this disease remains dismal. 2 Thus, describing the molecular mechanisms of HCC progression is essential for identifying novel therapeutic targets.
Cellular senescence has been characterized as a stress-induced, durable cell cycle arrest of previously replication-competent cells that serves to prevent cancers. 3 Impaired cellular senescence contributes to enhanced cancer cell proliferation and accelerated cancer progression. 3 Senescent cells have several fundamental features, including durable growth arrest, expression of anti-proliferative molecules and activation of damage-sensing pathways, leading to expression of many senescence-associated transcripts. 4, 5 The p53/ p21 signaling pathway is a well-established pathway in the scenario of senescence. p53 increases the activation of p21 transcription, thereby facilitating cellular senescence. 6 As a putative candidate for cancer treatment, p53/p21 signaling exerts a potent effect on senescence in various digestive system tumors, including HCC, 7 colorectal
cancer, 8 gastric cancer 9 and pancreatic cancer. 10 Circular RNAs (circRNAs) are a novel class of endogenous noncoding RNAs. Synthesized by back-splicing in which the head-to-tail splice junctions are joint together to form a circular transcript, circRNAs are conserved, stable, abundant, and expressed in a tissue-specific and cell-specific manner. 11 Published studies have described various functions of circRNAs, including sponging for mircoRNAs (miRNAs) to regulate gene transcription, interacting with RNA-binding proteins, and occasionally being translated into proteins. 12, 13 Since the discovery of the association of circRNAs with various solid and hematological malignancies, circRNAs have attracted much interest. Many of the reported cancer-related circRNAs are involved in malignancies of the digestive system. 14 circRNAs have also been demonstrated as potential diagnostic biomarkers for digestive system cancers. 15 circLARP4 is a recently identified circRNA derived from LARP4 gene locus. circLARP4 has been suggested to be a novel tumor suppressive factor and potential biomarker in gastric cancer. 16 However, the association of circLARP4
with HCC has not yet been elucidated.
Increasing evidence has suggested the involvement of miRNAs and long non-coding RNAs (lncRNAs) in cellular senescence.
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Nevertheless, our knowledge of the role of circRNAs in senescence is extremely limited. Highly expressed in heart samples of aged patients, circ-Foxo3 is reported to interact with senescence-associated proteins ID-1, E2F1, FAK and HIF1α, helping to induce senescence.
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CircPVT1, elevated in dividing cells and reduced in senescent fibroblasts, antagonizes endogenous let-7 to enable a proliferative phenotype, suppressing cellular senescence. 19 Of particular note, the role that circRNAs play in cellular senescence during tumorigenesis remains to be determined.
In the current study, we proposed that circLARP4 was a senescence-associated circRNA that induced cellular senescence and inhibited the proliferative phenotype in HCC. Mechanistically, circLARP4 sponged miR-761 to inhibit its actions on RUNX3, and thereby influenced HCC progression. circLARP4 was revealed as an independent prognostic factor for overall survival and recurrencefree survival in HCC patients.
| MATERIAL S AND ME THODS

| Patient samples
A total of 70 HCC tissues and paired peritumor samples were ob- 
| Cell lines and cell culture
The normal human liver cell line QSG-7701 and HCC cell lines Huh7, Hep3B, SMMC7721 and HepG2 were purchased from the Chinese Academy of Sciences Cell Bank (Shanghai, China). MHCC97L and HCCLM3 cell lines were obtained from the Liver Cancer Institute, Zhongshan Hospital, Fudan University (Shanghai, China). All cell lines were cultured in DMEM containing 10% FBS supplemented with 100 U/mL of penicillin and 100 μg/mL of streptomycin (HyClone, Logan, UT, USA). Cells were maintained at 37°C in a humidified atmosphere with 5% CO 2.
| RNA preparation and quantitative realtime PCR
The nuclear and cytoplasmic fractions were isolated using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Reverse transcription was performed with PrimeScript RT Master F I G U R E 2 circLARP4 suppresses hepatocellular carcinoma (HCC) proliferation and induces cellular senescence. A, circLARP4 overexpression in MHCC97L cells was validated by quantitative real-time PCR (RT-qPCR). B, circLARP4 knockdown in HCCLM3 was verified using RT-qPCR. C, Cell proliferation was analyzed by CCK-8 in circLARP4-overexpressed MHCC97L cells. D, Cell proliferation was analyzed by CCK-8 in circLARP4-silenced HCCLM3. E, EdU assays were adopted to assess the effects of circLARP4 overexpression or knockdown on HCC proliferation. F, Evaluation of the effects of circLARP4 on proliferation by colony formation assays. G, Cell cycle distribution was analyzed in MHCC97L cells with or without circLARP4 overexpression using flow cytometry. H, Cell cycle distribution was analyzed in HCCLM3 cells with or without circLARP4 knockdown using flow cytometry. I, Effects of circLARP4 on cellular senescence were examined using SA-β-gal staining. J, Western blotting results of the altered levels of p53 and p21 in circLARP4-overexpressed or circLARP4-silenced HCC cells. The data are shown as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 DH and U6 were used as internal controls. The relative expression was determined using the 2 −ΔΔCt method.
| FISH
Oligonucleotide-modified probe sequence for human circLARP4 and miR-761 was applied for FISH. Detailed procedures for FISH were reported previously.
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F I G U R E 3 circLARP4 directly targets miR-761 in hepatocellular carcinoma (HCC). A, Sequence alignment of circLARP4 with the binding sites in circLARP4 is shown. B, miR-761 levels in HCC tissues and paired peritumor samples were determined using quantitative real-time PCR (RT-qPCR). C, The negative relevance between circLAPR4 and miR-761 was revealed by Spearman's rank correlation analysis. D, miR-761 expression in circLARP4-overexpressed or circLARP4-silenced HCC cells. E, FISH analysis in HCCLM3 cells showing that circLARP4 was co-localized with miR-761 in the cytoplasm. F, Anti-AGO2 RIP was performed followed by quantitative real-time PCR (RT-qPCR) to detect circLARP4 and miR-761. G, The relative luciferase activity was determined after co-transfection with circLARP4 wide-type or mutant and miR-761 mimics or miR-NC. The data are shown as the mean ± SEM. **P < 0.01, ***P < 0.001 sh-RUNX3, GGCTAGCAGCATGCGGTATTT. miR-761 mimics and miR-761 inhibitor were purchased from RiboBio (Guangzhou, China).
| Cell proliferation assays and cell cycle analysis
Cell Counting Kit-8 (CCK-8), 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay and colony formation assay were used to investigate the proliferative capacity of HCC cells, as previously described. 
| SA-β-gal staining
Cellular senescence was determined using SA-β-gal staining 
| Western blotting and immunohistochemistry analysis
Western blotting was conducted as previously described. 
| Animal experiment
Four-week-old male nude mice were purchased from the Animal Core Facility of Nanjing Medical University (Nanjing, China).
Approximately 5 × 10 6 cells suspended in serum-free DMEM were subcutaneously injected into the flanks of the mice. The mice were monitored regularly. After 4 weeks, the mice were killed and xenografts were excised. The tumors were subjected to further RT-qPCR and immunohistochemistry analysis. All experiments with nude mice were performed strictly in accordance with a protocol approved by the Institutional Animal Care and Use Committee of Nanjing Medical University.
| Statistical analysis
Differences between groups were analyzed using the Wilcoxon Table S2 ) and recurrence-free survival (HR 2.347, 95% CI 1.119-4.923, P = 0.024; Table S3 ) in
HCC.
A previous report indicated that the subcellular location of circLARP4 in gastric cancer was primarily in cytoplasm. 16 We performed RT-qPCR of nuclear and cytoplasmic RNAs and demonstrated that circLARP4 was preferentially localized within the cytoplasm in HCC cells ( Figure 1G ). FISH analysis confirmed the cytoplasmic location of circLARP4 ( Figure 1H ). We indicated that circLARP4 was downregulated in HCC, and correlated with unfavorable clinicopathological features and survival outcome. F, Effects of circLARP4 on cellular senescence were assessed using SA-β-gal staining in circLARP4-overexpressed MHCC97L cells with or without RUNX3 knockdown. G, Western blotting of p53 and p21 expression in circLARP4-overexpressed MHCC97L cells with or without RUNX3 knockdown. The data are shown as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 F I G U R E 7 circLARP4 inhibits hepatocellular carcinoma (HCC) progression in vivo. A, circLARP4-overexpressed or circLARP4-silenced HCC cells were injected into nude mice. After 4 wk, the mice were killed to harvest the xenografts. B, Xenograft weight was measured in the circLARP4 overexpression group, the sh-circLARP4 group, and their controls. C, Tumor growth curve was plotted in the circLARP4 overexpression group, the sh-circLARP4 group, and their controls. D, Quantitative real-time PCR (RT-qPCR) analysis showed the consistent overexpression or knockdown of circLARP4 in xenograft. E, RT-qPCR analysis of the level of miR-761 in xenografts. F, HE, PCNA, RUNX3, p53 and p21 immunostaining of xenografts. The data are presented as the mean ± SEM. **P < 0.01, ***P < 0.001
F I G U R E 6 circLARP4 inhibits hepatocellular carcinoma (HCC) progression through the miR-761/RUNX3 axis. A, RUNX3 knockdown in MHCC97L cells was validated using quantitative real-time PCR (RT-qPCR
| circLARP4 suppresses hepatocellular carcinoma proliferation and induces cellular senescence
To evaluate the biological functions of circLARP4, we used lentiviruses to overexpress the level of circLARP4 in MHCC97L and to silence its expression in HCCLM3 cells. The overexpression or knockdown efficiency was validated using RT-qPCR (Figure 2A,B) .
CCK-8 assays showed that circLARP4 upregulation inhibited the proliferation of MHCC97L ( Figure 2C ), whereas circLARP4 knockdown increased the proliferative capacity of HCCLM3 ( Figure 2D ). 
Consistently
| circLARP4 directly targets miR-761 in hepatocellular carcinoma progression
Given that circLARP4 is mainly localized in the cytoplasm, in which circRNAs serve as a miRNA sponge to modulate gene expression, we next examined the capacity of circLARP4 to bind to miRNAs. We used starBase v2.0 (http://starbase.sysu.edu.cn/) 22 with a filter of very high stringency (number of supporting experiments ≥5) to predict the potential miRNAs that bind to circLARP4. Among them, miR-761 has previously been reported to be upregulated and play an oncogenic role in HCC progression, and was chosen for further validation.
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Potential binding sites of miR-761 were found within the circLARP4 sequence ( Figure 3A ). We then evaluated the level of miR-761 in 30
HCC tissues and matched peritumor samples, and confirmed its upregulation in liver cancer ( Figure 3B ). Further analysis revealed a negative correlation between circLARP4 and miR-761 level ( Figure 3C ).
Next, we measured miR-761 expression in circLARP4 overexpressed or silenced cells. miR-761 expression was remarkably decreased in circLARP4-overexpressed MHCC97L cells, while miR-761 expression was elevated in sh-circLARP4 HCCLM3 cells ( Figure 3D ). FISH analysis in HCC cells showed that circLARP4 was co-localized with miR-761 in cytoplasm ( Figure 3E ). Given that high degree of AGO2 occupancy in circLARP4 has been implicated previously, 16 we performed RIP for AGO2 in HCC cells and showed higher expression levels of circLARP4
and miR-761 in AGO2 pellet compared to those in the control group ( Figure 3F) . Subsequent luciferase reporter assays demonstrated that miR-761 was a direct target of circLARP4 ( Figure 3G ).
To investigate whether miR-761 reversed circLARP4-mediated suppression of HCC progression, we overexpressed miR-761 in MHCC97L cells using mimics ( Figure 4A ). CCK-8 and EdU assays confirmed that miR-761 mimics restored the inhibitory effects of circLARP4 on HCC growth ( Figure 4B,C) . Cell cycle analysis showed that G1/S arrest was ameliorated by miR-761 mimics ( Figure 4D ). Consistently, miR-761 overexpression reversed the cellular senescence in MHCC97L ( Figure 4E,F) .
Together, the results supported that the suppressive effect of circLARP4 on HCC progression was mediated by miR-761.
| circLARP4 inhibits hepatocellular carcinoma progression via miR-761/RUNX3 signaling pathway
To further elucidate the underlying mechanisms of the circLARP4/miR-761 axis in HCC, we used TargetScan, miRWalk, miRDB and DIANA databases to predict the targets of miR-761 ( Figure 5A ). Of particular interest to us was RUNX3 among the potential targets predicted by all 4 algorithms. Decreased RUNX3 expression has been previously reported in HCC. 24 In addition, RUNX3 suppresses HCC tumorigenesis via p53 and p21. 25, 26 Therefore, we speculated that RUNX3 might be a downstream target of miR-761. We performed RT-qPCR to verify the downregulated RUNX3 expression in HCC (
Figure 5B), and found that miR-761 expression was negatively correlated with RUNX3 expression ( Figure 5C ). miR-761 overexpression led to a decrease in RUNX3 level, whereas miR-761 knockdown resulted in increased RUNX3 expression ( Figure 5D ). Luciferase reporter assays revealed that RUNX3
was a direct target of miR-761 ( Figure 5E ).
To confirm that RUNX3 was the downstream effector of the circLARP4/miR-761 axis, we knocked down RUNX3 in circLARP4-overexpressed MHCC97L cells ( Figure 6A,B) . Rescue experiments were performed, including CCK-8, EdU, flow cytometry and SA-β-gal staining ( Figure 6C-F) . The results showed that the inhibited malignant phenotypes induced by overexpressing circLARP4 were restored by RUNX3
silence. Moreover, the increased levels of p53 and p21 in circLARP4-overexpressed MHCC97L were abolished after RUNX3 knockdown ( Figure 6G ). Collectively, we showed that circLARP4 exerted its tumor suppressive functions through miR-761/RUNX3 signaling pathway.
| circLARP4 inhibits hepatocellular carcinoma progression in vivo
To probe the biological functions of circLARP4 in vivo, we constructed a nude mouse xenograft model. Mice injected with circLARP4-overexpressed MHCC97L cells developed significantly smaller tumor volumes than those injected with MHCC97L Lv-con cells. In contrast, mice inoculated with HCCLM3 sh-circLARP4 cells presented larger tumors than the control group ( Figure 7A,B) . The growth curve indicated that the xenograft growth was slower in the circLARP4-overexpressed MHCC97L group, whereas xenografts derived from HCCLM3 sh-circLARP4 cells grew faster than those from the control group ( Figure 7C ). Xenografts were subjected to RT-qPCR assays to confirm that the overexpression or knockdown of circLARP4 was persistent in the xenograft model ( Figure 7D ). In addition, the miR-761 level was lower in xenografts of the circLARP4-overexpressed MHCC97L group, whereas miR-761 was higher in xenografts derived from the HCCLM3 shcircLARP4 group ( Figure 7E ). Immunohistochemistry analysis indicated a lower expression of PCNA and higher levels of RUNX3, p53 and p21 in the circLARP4-overexpressed MHCC97L group as compared with those in the control group. Conversely, xenografts originating from HCCLM3 sh-circLARP4 cells presented increased PCNA expression and decreased levels of RUNX3, p53 and p21
( Figure 7F ). In sum, circLARP4 hindered HCC growth and promoted p53 and p21 in vivo.
| D ISCUSS I ON
To the best of our knowledge, the present study is the first that synovial sarcoma 35 and non-small cell lung cancer. 36 We identified that miR-761 was the downstream target of circLARP4, and was associated with circLARP4-mediated cellular senescence in HCC.
To gain clues of the target gene of the circLARP4/miR-761 axis in HCC, we combined 4 different bioinformatics algorithms and RUNX3
was predicted as the potential downstream target. Further experiments revealed that RUNX3 was the downstream effector of the circLARP4/miR-761 axis and mediated cellular senescence in HCC.
RUNX3 has been well established as a tumor suppressor. [37] [38] [39] In HCC, aberrant CpG methylation could also contribute to RUNX3 downreg- has also been reported as a direct downstream target of RUNX3.
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Given that p53 and p21 are 2 crucial modulators contributing to cellular senescence, we examined whether the expression of p53 and p21 could be altered by the circLARP4/miR-761/RUNX3 signaling.
The results showed that circLARP4 affected cellular senescence via the p53/p21 signaling through regulating the miR-761/RUNX3 axis.
In summary, we identified that circLARP4 induced cellular senescence, thereby inhibiting HCC progression. Low circLARP4 expression was positively correlated with unfavorable clinicopathological features and was an independent predictor for HCC patient survival. Mechanistic studies showed that circLARP4 sponged miR-761 to regulate RUNX3, thus affecting the expression levels of p53 and p21. The regulatory axis of circLARP4/miR-761/RUNX3/ p53/p21 contributed to a better understanding of senescenceassociated circRNAs in HCC progression. Targeting circLARP4 is be a promising therapeutic candidate for HCC treatment.
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